Replying to @marklewismd
Too many doctors are becoming hooked on the dopamine rush of RTs and likes. Have they forgotten their fiduciary responsibility to patients?
I'm sorry as well. We deserve better, and doctors must do better by sharing less.
Matthew Katz, MD 🇺🇸🟦
108.8K posts
Matthew Katz, MD 🇺🇸🟦
@subatomicdoc
I'm a doctor dedicated to improving health and cancer care. Trust, learn, collaborate. Neutral good. He/him. עם ישראל חי
- After over 20 years caring for thousands of cancer patients, what would you do next? In four days, I begin as Interim Chair of Radiation Oncology and Residency Program Director @TuftsMedicalCtr. This new role will let me help through leadership, learning, and collaboration.
- Replying to @DrJenGunterIt is cause for formal complaint if helpful to you. "Intrusion upon seclusion" based upon Canadian law. Jones v Tsige lawnow.org/intrusion-upon…
- Replying to @marklewismd @sportswithjohn and 3 othersThanks for the connection. What can I do to help?
- If you're interested to see what infectious disease specialists are saying, here are 300+ of them. @DrJRMarcelin @GermHunterMD @jdcooperid please let me know if I am missing anyone #IDTwitter x.com/i/lists/123876…
- It has been a hard year, but my son has now made his choice for college. Mazel tov on his decision to join @Stanford's Class of 2025! May he thrive, with the opportunity to further challenge himself and find how best to help make our world a little better. 🎉😊💙
- I rarely get personal about family. But I could not be happier for my eldest who has decided to join @NorthwesternU Class of 2024! An exciting transition for the first of my children, all better than I am. Mazel tov #wildkatz
- Oncology = knowledge of tumors. Patients are experiential oncologists. Caregivers are supportive care oncologists. What if we started an inclusive society of digital oncology dedicated to improving knowledge & cancer care? #patientsincluded #s4pm 🤔
- Top 10 Best-Selling Cancer Drugs 2018 genengnews.com/a-lists/top-10… 5. Bevacizumab $6.8B +2.4% 4. Trastuzumab $6.95B -0.5% 3. Pembrolizumab $7.2B +88% 2. Nivolumab $7.6B +31% 1. Lenalidomide $9.7B +18% All #radonc is less costly than any one of them @oncology_bg @VPrasadMDMPH
- @LouiseMensch Consistent to a fault.
- Replying to @grok_Please remind the Vice Chancellor that ‘end-of-pandemic’ hopes do not reduce the risk of transmission. BA.2 will be a reminder I suspect, hopefully I am wrong.
- So Western Europe and UK is headed back upwards. Spain is now matching the July peak in the US for new cases/day adjusted for population. Summer fun catching up with us, school, or something else?
